Close

IT & Data Management

CPhI 2019: SternMaid displays a comprehensive service portfolio revolving around the contract manufacturing of powder products for special medicinal nutrition situations.

At this year’s CPhI in Frankfurt, at Stand 90B12, contract manufacturer SternMaid will be presenting its offerings relating to the blending, processing and filling of powdered health food and other medicinal nutrition products. Affiliated company and co-exhibitor SternLife will...

Aptar Enters into Strategic Partnership with PureCycle to Accelerate Integration of Ultra-Pure Recycled Polypropylene into Dispensing Solutions

AptarGroup, Inc., a global leader in dispensing, drug delivery and active packaging solutions, announced that it has partnered with PureCycle Technologies, to prepare for the introduction of PureCycle’s Ultra-Pure Recycled Polypropylene (UPRP) into dispensing applications. PureCycle’s ground-breaking, patented recycling process,...

The CPhI Annual Report: take part in pharma’s largest reputation survey

The global pharmaceutical landscape is evolving at an extraordinary pace as manufacturing capabilities, drug development technologies, and regulation advances creating new ways of innovating drugs and better serving patients. CPhI Worldwide is using its unrivalled access to pharmaceutical professionals and...

GSK grants exclusive technology license for clinical-stage Ebola vaccines to Sabin Vaccine Institute

GSK and the Sabin Vaccine Institute (Sabin) announced exclusive agreements for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Ebola Zaire, Ebola Sudan and the closely related, but lesser known, Marburg virus. No licensed...

Mylan and Biocon Launch First Trastuzumab Biosimilar Ogivri in Australia

Biocon Ltd. and Mylan N.V. announced the launch in Australia of Ogivri™ (trastuzumab), a biosimilar to Herceptin®1 (trastuzumab), for the treatment of HER2-overexpressing breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma). Ogivri is the first trastuzumab biosimilar...

JCDC the Research Arm of Jehangir Hospital Is the First Hospital in India to Join Clinerions Patient Network Explorer Platform

JCDC is the research arm of Jehangir Hospital, Pune, India. The hospital has over 350 beds, servicing patients throughout Pune and beyond. It has a wide range of disease-area specializations, including, but not limited to: cardiology, oncology, endocrinology, pediatrics,...

Boston Analytical Continues Expansion with Office in Cambridge MA

Boston Analytical, a leading provider of analytical and microbiological testing to the pharmaceutical industry, has opened an office in downtown Cambridge. This expansion comes two years after opening a 30,000 square foot, state-of-the-art facility in Salem, NH, and one...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read